Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05856409 | Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence | unknown | — | 20 | RenJi HospitalOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT03363867 | BEACON - ABC in Recurrent Platinum Resistant HGSOC(BEACON) | unknown | Phase 2 | 30 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05976113 | A Retrospective Study on Multiple Classifier Endometrial Cancer | unknown | — | 80 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05976932 | Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer | unknown | — | 20 | Fudan UniversityOTHER | 0 | Aug 4, 2023 | clinicaltrials |
| NCT05318625 | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05874115 | Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer(OutCoME) | unknown | — | 75 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05969405 | Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy | unknown | — | 400 | Far Eastern Memorial HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05965141 | Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer | unknown | Phase 1 / Phase 2 | 38 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 0 | Jul 28, 2023 | clinicaltrials |
| NCT05078307 | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids(VAPOHYSTERO) | unknown | N/A | 54 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05942209 | ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound | unknown | — | 766 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05955079 | Circulating Tumor DNA Study in Patients With Endometrial Cancer(ctDNA-endo) | unknown | — | 130 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05690906 | Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer | unknown | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05931354 | Longitudinal HPV Pap in CIN and VAIN(LHPCV) | unknown | — | 600 | Chang Gung Memorial HospitalOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT05925361 | Peritoneum Vaginoplasty; Implementation According to IDEAL Framework(PeriVaS) | unknown | N/A | 13 | Amsterdam UMC, location VUmcOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT04201561 | High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy(SELENIUM) | unknown | Phase 3 | 68 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04678102 | Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)(CREATIVE) | unknown | Phase 1 | 36 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT03024398 | Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer(Sentimetre) | unknown | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT04699006 | Efficacy and Adverse Effects of Olaparib in Ovarian Cancer. | unknown | — | 245 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05902390 | The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy. | unknown | N/A | 106 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05904977 | Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer | unknown | — | 460 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05894915 | Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach | unknown | N/A | 390 | Peking University People's HospitalOTHER | 0 | Jun 8, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT) | unknown | Phase 1 / Phase 2 | 200 | Western Sydney Local Health DistrictOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883670 | Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer | unknown | — | 118 | Shandong UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05881967 | Molecular Mechanism Study of Uterine Sarcoma | unknown | — | 300 | Shixuan WangOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05879796 | Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer | unknown | — | 30 | Peking University Third HospitalOTHER | 0 | May 30, 2023 | clinicaltrials |
| NCT05606263 | Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer(GCR-05) | unknown | Phase 2 | 55 | Xi'an Jiaotong UniversityOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05877911 | Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy | unknown | Phase 2 | 110 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | May 26, 2023 | clinicaltrials |
| NCT04761146 | A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer(DaRT-V) | unknown | N/A | 10 | CCTU- Cancer ThemeOTHER | 1 | May 25, 2023 | clinicaltrials |
| NCT05863260 | Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer | unknown | — | 60 | Fudan UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05863377 | Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer | unknown | — | 450 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 18, 2023 | clinicaltrials |
| NCT05216913 | Optimising Cardiovascular Health in Endometrial Cancer Survivors(OPTIMUS) | unknown | — | 80 | University of ManchesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05749211 | Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer | unknown | N/A | 59 | Ruijin HospitalOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT03691012 | Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer | unknown | — | 118 | Walter and Eliza Hall Institute of Medical ResearchOTHER | 2 | May 9, 2023 | clinicaltrials |
| NCT05851079 | Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions | unknown | — | 15,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05824494 | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | unknown | Phase 2 | 58 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 6, 2023 | clinicaltrials |
| NCT05840029 | VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES | unknown | — | 68 | Alexandria UniversityOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT04240262 | Microwave Ablation for Leiomyoma(MYOMIC2) | unknown | — | 200 | Karolinska InstitutetOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05430906 | AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer | unknown | Phase 2 | 40 | Hunan Cancer HospitalOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05823194 | Infertility and Pregnancy Outcomes of Fertility Spared Gynecological Oncology Patients | unknown | N/A | 50 | Acibadem UniversityOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05824247 | A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer | unknown | — | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05170087 | Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies | unknown | — | 1,200 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05819060 | The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05816005 | Performance of Whole Body MRI in Extraplevic Disease Detection in Patients Undergoing Pelvic Exenteration for Gynecological Maligniancies(WHOLE BODY) | unknown | — | 71 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05812677 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05813509 | Individualized Precision Treatment Based on Ovarian Cancer Organoid Model | unknown | N/A | 30 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 14, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 16, 2023source: clinicaltrials